Literature DB >> 15975690

Multiple correspondence analysis in S-PLUS.

Federico Ambrogi1, Elia Biganzoli, Patrizia Boracchi.   

Abstract

Multiple correspondence analysis (MCA) is a multivariate method for analyzing multidimensional contingency tables. General software procedures to perform MCA are available. Among them SAS Proc CORRESP, SPAD CORMU procedure and the mca function of the MASS library in S-PLUS are probably the most used. However, CORRESP and CORMU output is different from that of mca function. The aim of this short note is showing how to obtain from mca function results compatible with those achieved with SAS or SPAD. A modified code is proposed in order to obtain the same coordinate system computed by SAS and SPAD. Moreover, the computation of the contributions of the levels of the factors to the inertia explained by each axis, the squared cosine of each factor level and the re-evaluation of the inertia explained by each axis have been added in order to improve the interpretations of the results of the decomposition.

Entities:  

Mesh:

Year:  2005        PMID: 15975690     DOI: 10.1016/j.cmpb.2005.03.001

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  3 in total

1.  Terpenoids as potential chemopreventive and therapeutic agents in liver cancer.

Authors:  Roslin J Thoppil; Anupam Bishayee
Journal:  World J Hepatol       Date:  2011-09-27

2.  The validity of cocaine dependence subtypes.

Authors:  Henry R Kranzler; Marsha Wilcox; Roger D Weiss; Kathleen Brady; Victor Hesselbrock; Bruce Rounsaville; Lindsay Farrer; Joel Gelernter
Journal:  Addict Behav       Date:  2007-05-24       Impact factor: 3.913

3.  The Multiple Correspondence Analysis Method and Brain Functional Connectivity: Its Application to the Study of the Non-linear Relationships of Motor Cortex and Basal Ganglia.

Authors:  Clara Rodriguez-Sabate; Ingrid Morales; Alberto Sanchez; Manuel Rodriguez
Journal:  Front Neurosci       Date:  2017-06-20       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.